ZFP36L1 and neoplasm: The expression of ZFP36L1 was significantly higher in patients with a high-grade tumor (p =0.048 < 0.05) (Figure 2A), a high-TNM stage tumor (p = 0.036 < 0.05) (Figure 2B), and a high-tumor (T) stage tumor (p = 0.017 < 0.05) (Figure 2C), but showed no association with metastasis (M) stage (p = 0.33) and node (N) stage (p = 0.42) (Figures 2D,E).